Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT06683794
Predicts Mortality by AST/ALT Ration in Patients with Sepsis and Septic Shock During ICU Admissin
Sponsor: Nermeen Gamil Ahmed
View on ClinicalTrials.gov
Summary
1\_The study predicts mortality by using Asparate aminotransferase (AST) to Alanine aminotransferase (ALT) ratio in patients with sepsis and septic shock during the duration of ICU admission and for one month after discharge. 2- Compare between APACHE II and AST/ALT ratio as prognostic factors in patients with sepsis and septic shock.
Official title: The Prognostic Value of the AST/ALT Ratio Vs. APACHE II Score in Patients with Sepsis and Septic Shock
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
142
Start Date
2024-11-01
Completion Date
2025-12-01
Last Updated
2024-11-12
Healthy Volunteers
No